Australia markets close in 28 minutes

Seer, Inc. (SEER)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.7500-0.0200 (-1.13%)
At close: 04:00PM EDT
1.7700 +0.02 (+1.14%)
After hours: 07:40PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.7700
Open1.7400
Bid1.7400 x 200
Ask1.7700 x 300
Day's range1.7050 - 1.7700
52-week range1.4550 - 5.6500
Volume245,377
Avg. volume495,712
Market cap113.353M
Beta (5Y monthly)1.65
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Seer to Report First Quarter 2024 Financial Results on May 8, 2024

    REDWOOD CITY, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the first quarter 2024 on Wednesday, May 8, 2024. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investor section of Seer’s website at investor.se

  • GlobeNewswire

    Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook

    Enhanced access to the Proteograph Product Suite and demonstrated its power with new customer dataREDWOOD CITY, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the fourth quarter and full year ended December 31, 2023. Recent Highlights Achieved revenue of $4.4 million for the fourth quarter of 2023, a decrease of 4% over the fourth quarter of 2022, a

  • GlobeNewswire

    Seer to Participate in the TD Cowen 44th Annual Health Care Conference

    REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming TD Cowen 44th Annual Health Care Conference in Boston, MA. Seer’s management is scheduled to participate in a fireside chat and Q&A session on Monday, March 4th at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time. A live webcast of the session will be avai